Repligen Cp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | BMY | AMGN | GILD | MRNA |
| Company | Repligen Cp | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 165.66 | 44.68 | 265.72 | 65.50 | 106.18 |
| High | 167.52 | 45.37 | 271.68 | 66.35 | 108.15 |
| Low | 165.05 | 44.34 | 265.72 | 64.63 | 105.25 |
| Last | 167.64 | 45.04 | 270.02 | 65.43 | 107.81 |
| Change | +1.98 | +0.34 | +0.64 | +0.16 | +1.63 |
| % Change | +1.20% | +0.76% | +0.24% | +0.25% | +1.54% |
| Volume | 135,430 | 8,384,625 | 578,440 | 6,443,764 | 780,604 |
| 20-Day Average Volume | 470,317 | 12,547,163 | 2,062,876 | 6,759,225 | 2,977,139 |
| Previous Close | 165.66 | 44.70 | 269.38 | 65.27 | 106.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 169.98 | 49.49 | 269.98 | 68.31 | 105.03 |
| 20-Day Raw Stochastic | 45.53% | 9.50% | 39.17% | 12.17% | 53.86% |
| 20-Day Relative Strength | 42.23% | 31.45% | 45.25% | 30.68% | 54.13% |
| Weighted Alpha | +1.02 | -33.53 | +9.34 | -23.07 | -10.30 |
| Today's Opinion | 40% Sell | 88% Sell | 72% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 24% Sell | 88% Sell | 72% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 40% Buy | 8% Buy | 40% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.35% since 04/19/24 | -7.46% since 04/19/24 | +0.32% since 04/19/24 | -1.63% since 04/19/24 | +5.68% since 04/19/24 |
| Low | 154.87 on 04/22/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 99.30 on 04/22/24 |
| High | 174.30 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | -9.10% since 03/26/24 | -13.83% since 03/26/24 | -4.26% since 03/26/24 | -9.30% since 03/26/24 | -0.22% since 03/26/24 |
| Low | 152.19 on 04/18/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 97.00 on 04/03/24 |
| High | 187.25 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -13.59% since 01/26/24 | -8.89% since 01/26/24 | -13.47% since 01/26/24 | -17.41% since 01/26/24 | +5.27% since 01/26/24 |
| Low | 152.19 on 04/18/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 84.06 on 02/13/24 |
| High | 211.13 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +36.42% since 10/26/23 | -14.52% since 10/26/23 | +0.03% since 10/26/23 | -16.34% since 10/26/23 | +41.06% since 10/26/23 |
| Low | 110.45 on 10/30/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 62.55 on 11/02/23 |
| High | 211.13 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,250,289 | 90,596,128 | 144,488,960 | 81,266,176 | 40,654,200 |
| Shares Outstanding, K | 55,839 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 638,760,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 41,580,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 155,740,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -25,490,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 1.02 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 02/21/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/01/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 97.03 | 6.51 | 14.64 | 9.98 | 0.00 |